Blood Advances Talks
By Blood Advances Talks
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Blood Advances Talks
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 11
Reviews: 0
Episodes: 28
Description
Blood Advances, a Journal of the American Society of Hematology, provides an open international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences.
Music for Blood Advances Talks is preformed by the Art Topilow Trio
| Episode | Date |
|---|---|
|
GRNDaD: big data and sickle cell disease
|
Feb 09, 2022 |
|
Investigational curative gene therapy approaches to sickle cell disease
|
Jan 26, 2022 |
|
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
|
Jan 26, 2022 |
|
Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding
|
Oct 01, 2021 |
|
Concizumab: a novel anti-TFPI therapeutic for hemophilia
|
Jan 12, 2021 |
|
Naive T-cell depletion in stem cell transplantation
|
Oct 13, 2020 |
|
The management of venous thromboembolism in hospitalized patients with COVID-19
|
Sep 15, 2020 |
|
Gene therapy for hemophilia: anticipating the unexpected
|
Sep 15, 2020 |
|
The changing landscape of anticoagulation in cancer-associated thrombosis
|
Mar 10, 2020 |
|
TA-TMA: state of the art for diagnosis and treatment
|
Jan 14, 2020 |
|
Inherited predisposition to myeloid malignancies
|
Sep 10, 2019 |
|
Managing patients who are receiving warfarin (or DOAC)and need an elective surgery or procedure
|
Jun 25, 2019 |
|
Daily light-and-darkness onset regulates mouse hematopoietic stem cells
|
Feb 26, 2019 |
|
Extended therapy for unprovoked venous thromboembolism: when is it indicated?
|
Feb 12, 2019 |
|
Antiplatelet therapy in the management of atherothrombosis: recent clinical advances
|
Jul 27, 2018 |
|
Challenges facing the benign hematology physician-scientist workforce
|
Feb 13, 2018 |
|
Choosing for whom to recommend allogeneic transplantation for AML in CRL
|
Jan 23, 2018 |
|
Catalyzing innovation in clinical trial design and analysis at NHLBI
|
Jan 11, 2018 |
|
ITP and thrombosis: an intriguing association
|
Nov 16, 2017 |
|
The current therapeutic landscape of FLT3 inhibitors
|
Nov 16, 2017 |
|
How many mice? Design considerations for murine studies
|
Aug 15, 2017 |
|
The Direct Oral Anticoagulants – can we finally stop using rat poison?
|
Jun 19, 2017 |
|
Impact of the ICAL on the treatment of acute leukemia
|
Mar 15, 2017 |
|
Venetoclax: a primer
|
Feb 28, 2017 |
|
Technological Solutions For Global Hematology And Oncology
|
Feb 22, 2017 |
|
The Lucky Iron Fish: a simple solution for iron deficiency
|
Jan 24, 2017 |
|
New developments in the management of sickle cell disease
|
Dec 01, 2016 |
|
Should we avoid heparin to eliminate HIT?
|
Dec 01, 2016 |